| Financial Year |
March 31 2023 |
| Monetary Funds |
195,480,000.50 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
158,814,792.90 |
| Accounts Receivable |
865,047,879.16 |
| Advances to Suppliers |
137,755,019.67 |
| Other Receivables |
134,722,097.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
632,017,688.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
120,170,364.06 |
| Total Current Assets |
2,268,227,512.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,500,000.00 |
| Long-term Equity Investment |
29,657,469.93 |
| Investment Properties |
-- |
| Fixed Assetes |
908,638,424.49 |
| Under-construction Projects |
347,197,156.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
208,300,723.05 |
| R&D expenses |
-- |
| Goodwill |
85,591,101.50 |
| Long-Term Deferred and Prepaid Expenses |
41,570,933.27 |
| Deferred Income Tax Assets |
31,201,346.23 |
| Other Non-Current Assets |
80,422,013.81 |
| Sub-Total of Non-Current Assets |
1,783,912,468.66 |
| Total Assets |
4,052,139,980.91 |
| Short-Term Loans |
821,239,982.98 |
| Trading Financial liabilities |
1,102,550.00 |
| Notes Payable |
118,190,285.01 |
| Accounts Payable |
530,127,326.69 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,660,471.99 |
| Taxes Payable |
22,414,921.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,954,323.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
137,361,422.18 |
| Other Current Liabilities |
128,830,054.04 |
| Sub-Total of Current Liabilities |
1,846,364,661.32 |
| Long-term Loans |
346,436,955.70 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
76,425,700.14 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,506,003.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
463,242,778.76 |
| Total Liabilities |
2,309,607,440.08 |
| Paid-In Capital(Or Share Stock) |
93,333,334.00 |
| Capital Surplus |
886,038,332.39 |
| Surplus Reserve |
46,666,667.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
528,233,281.62 |
| Minority Stockholder's Interest |
176,636,672.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,565,895,867.95 |
| Owner's Equity（Stockholder's Equity） |
1,742,532,540.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,052,139,980.91 |
